With a clear and specific definition of the transcriptome of dystrophin deficiency, manipulation of identified dysregulated molecules downstream of dystrophin may lead to novel ameliorative approaches for DMD. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.